Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs as Adjuvant Therapy in Group E COPD
NCT07441226Phase 2Recruiting
- Sponsor
- RSUP Persahabatan
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in chronic obstructive pulmonary disease (COPD), sponsored by RSUP Persahabatan. Started Aug 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07441226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07441226.